ARTICLE | Clinical News
RP101: Interim Phase II data
June 12, 2006 7:00 AM UTC
Interim data from an ongoing, 8-month, double-blind, placebo-controlled, German Phase II trial in 22 patients with metastatic pancreatic cancer showed that after 6 months 41% of patients were still al...